Positioning of subdomain IIId and apical loop of domain II of the hepatitis C IRES on the human 40S ribosome by Babaylova, E. et al.
Published online 7 January 2009 Nucleic Acids Research, 2009, Vol. 37, No. 4 1141–1151
doi:10.1093/nar/gkn1026
Positioning of subdomain IIId and apical loop of
domain II of the hepatitis C IRES on the human
40S ribosome
Elena Babaylova1, Dmitri Graifer1, Alexey Malygin1, Joachim Stahl2,
Ivan Shatsky3 and Galina Karpova1,*
1Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences,
Novosibirsk, 630090, Russia, 2Max-Delbru¨ck-Centrum fu¨r Molekulare Medizin (MDC), Berlin-Buch, 13092 Berlin,
Germany and 3Belozersky Institute of Physico-Chemical Biology, Moscow State University, Moscow, 119899,
Russia
Received September 11, 2008; Revised November 19, 2008; Accepted December 9, 2008
ABSTRACT
The 5’-untranslated region of the hepatitis C virus
(HCV) RNA contains a highly structured motif
called IRES (Internal Ribosome Entry Site) responsi-
ble for the cap-independent initiation of the viral
RNA translation. At first, the IRES binds to the 40S
subunit without any initiation factors so that the ini-
tiation AUG codon falls into the P site. Here using an
original site-directed cross-linking strategy, we
identified 40S subunit components neighboring sub-
domain IIId, which is critical for HCV IRES binding to
the subunit, and apical loop of domain II, which was
suggested to contact the 40S subunit from data on
cryo-electron microscopy of ribosomal complexes
containing the HCV IRES. HCV IRES derivatives
that bear a photoactivatable group at nucleotide
A275 or at G263 in subdomain IIId cross-link to ribo-
somal proteins S3a, S14 and S16, and HCV IRES
derivatized at the C83 in the apex of domain II
cross-link to proteins S14 and S16.
INTRODUCTION
Hepatitis C virus (HCV) is one of the most dangerous
human pathogens. It infects about 180 million people
worldwide (1) and can lead to cirrhosis, hepatocellular
carcinoma and other damages of the liver (2,3). HCV is
a flavivirus whose genome consists of one positive 9600
nucleotide-long RNA strand lacking a cap at the
50-terminus (4). One of the key steps of the HCV life
cycle in human host cells is initiation of viral RNA trans-
lation. It is mediated by a specific highly structured
motif comprising nucleotides 40–372 of the viral RNA;
it includes the 50 untranslated region and the adjacent
part of the coding sequence, and is known as IRES
(Internal Ribosomal Entry Site) (5–7) (Figure 1). The
HCV IRES is responsible for cap-independent internal
initiation of translation; it is an alternative to the conven-
tional mechanism generally used by capped eukaryotic
cellular mRNAs involving a number of initiation factors
that provide association of the mRNA to the cap, leading
40S ribosome binding and scanning to the initiation codon
(6). The organization of domains and several RNA motifs
in the domains are conserved among different strains of
HCV and related viruses of the Flaviridae family (6,8,9).
The HCV IRES folds under physiological ionic conditions
into a defined 3D structure whose integrity is essential for
efficient IRES-mediated translation (10); spatial structures
of the HCV IRES domains have already been resolved by
X-ray crystallography and NMR (11).
The sequence of events leading to the formation of 80S
initiation complex with IRES competent for the start of
viral RNA translation is well known (12–14). The func-
tional roles of individual IRES domains and subdomains
have been studied using mutant IRESes (6,12–16), cross-
linking with chemically reactive derivatives of oligonucleo-
tides complementary to target RNA sequences (17), and
enzymatic and chemical footprinting (15,16,18).
According to the generally accepted model, in the first
step of the assembly of the 80S initiation complex, the
HCV IRES forms a stable binary complex with the 40S
subunit where the initiation codon is positioned on the
P site without any initiation factors. Binary complex for-
mation crucially depends on the basal portion of domain
III (mainly hairpins IIId and IIIe) and on the four-way
junction IIIabc (Figure 1). Thereafter, eIF3 and the ter-
nary complex (eIF2Met-tRNAiMet GTP) assemble to
form a 48S preinitiation complex; binding of eIF3 is
mediated by domain IIIb and four-way junction IIIabc.
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Binding of eIF5 to this complex promotes hydrolysis of
eIF2-bound GTP and subsequent release of eIF2GDP,
which is modulated by HCV IRES domain II (14).
Finally, the release of the remaining factor eIF3 requires
eIF5B and GTP hydrolysis and occurs during joining of
the 60S subunit to form the 80S initiation complex.
Knowledge concerning the ribosomal components
responsible for binding of HCV IRES is important to
understand the mechanism of translation initiation of
the viral RNA and could be essential for the development
of novel efficient therapies for HCV. However, the struc-
tural organization of the IRES-binding site on the 40S
subunit is less studied than the functional role of the
domains, and the resulting data are rather contradictory.
Direct UV-induced cross-linking of HCV IRES to the
40S subunit revealed ribosomal protein S5 as the only
Figure 1. Structural organization of the HCV IRES (7), the initiation AUG codon is underlined. RNA sequences complementary to deoxy-oligomers
used for site-specific modification of the HCV IRES are marked with thick lines with arrows indicating the 50-phosphates derivatized with alkylating
groups. RNA sequences complementary to helper oligomers used together with the alkylating derivatives are marked with dotted lines. Nucleotides
of the HCV IRES cross-linked to the oligonucleotide derivatives are shaded.
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target for cross-linking (19). Other investigators using
HCV IRES with uridines randomly substituted by
4-thiouridines reported cross-linked proteins S2, S3, S10,
S15, S16/S18 and S27 (20). These studies highlighted a set
of proteins that could surround the 50-terminal part of
HCV RNA, but did not provide information on the spe-
cific ribosomal proteins neighboring particular RNA
nucleotides. Based on the cross-linking results and the
data on inability of 40S subunits from lower eukaryotes
to bind HCV IRES, it was suggested that the IRES-bind-
ing site on the 40S subunit is formed by protein sequences
specific of higher eukaryotes rather than by the 18S rRNA
that is fairly similar between yeast and human (78% iden-
tity) [(20) and refs therein].
Cryo-electron microscopic (cryo-EM) visualization of
HCV IRES in its complexes with the 40S subunit (21)
and the 80S ribosome (22) provided a general idea of the
positioning of the IRES on the ribosome; two ribosomal
proteins, namely, S5 on the head of the subunit interface
and S14 on the platform were mapped close to the apex of
domain II of the IRES (22). However, domain II in con-
trast to subdomains IIId/e and the four-way junction
IIIabc is not essential for binding of HCV IRES to 40S
subunit (see above). Thus, ribosomal proteins that could
contact keystone structural elements of HCV IRES lead-
ing to its high affinity for the 40S subunit remained
unknown.
Highly sensitive tools to investigate the molecular envir-
onments of RNA ligands bound to the ribosome are RNA
derivatives bearing a perfluorophenyl azide cross-linker at
specific locations. Using a set of short mRNA analogues
bearing such groups at the specific locations, the structure
of the mRNA-binding channel of the human 80S ribo-
some has been studied in detail (23–26). The data on ribo-
somal components neighboring mRNA nucleotides in
positions 9 to +12 with respect to the first nucleotide
of the P site codon were recently confirmed in a study
of 48S initiation complexes using mRNAs bearing
4-thiouridines capable of forming ‘zero-length’ cross-
links (27). This additionally demonstrated that perfluoro-
phenyl azide-modified RNAs provide correct and
adequate information on the structures of binding sites
of various RNA ligands bound to the mammalian ribo-
some. Recently, we suggested a novel strategy that makes
it possible to selective introduce perfluorophenyl azide
groups into long structured RNAs (28). This strategy
is based on the site-specific alkylation of an RNA with
[4-(N-2-chloroethyl-N-methylamino)benzyl]phosphor-
amide derivatives of oligodeoxyribonucleotides comple-
mentary to a sequence adjacent to the target site. After
hydrolysis of the phosphoramide bond in the covalent
adduct formed, aryl azide moiety is selectively introduced
at the liberated benzylamine group. Using HCV IRES
derivative bearing the cross-linker at A296 in hairpin
IIIe for a site-directed cross-linking study on human ribo-
somes, we determined the ribosomal components neigh-
boring this keystone subdomain in the binary complex of
the IRES with the 40S subunit. This approach makes it
possible to monitor the molecular environment of each of
structural elements of the IRES on the ribosome at every
step of translation initiation of the viral RNA.
In this study, applying the strategy based on site-specific
modification, we obtained HCV IRES derivatives bear-
ing a perfluorophenyl azide group at various nucleotides
in hairpin IIId or in the apex of domain II (Figure 1),
and with the use of these derivatives determined the ribo-
somal components neighboring these nucleotides in the
binary complex of HCV IRES with the human 40S ribo-
somal subunit. The results obtained show which riboso-
mal components neighbor the structural elements of
HCV IRES critical for its binding to the 40S subunit
and which components surround the apex of domain II
that is located close to the ribosomal surface based on
cryo-EM data.
MATERIALS AND METHODS
Acrylamide, N,N0-methylene-bis-acrylamide and urea
were purchased from AppliChem, ribonucleoside tripho-
sphates were from Sigma, Sephadex G-75 from Pharmacia
and T7 RNA polymerase from NEB. DNA oligomers
complementary to definite sequences of the HCV IRES
were synthesized in the Laboratory of Medical
Chemistry (Institute of Chemical Biology and Fundamen-
tal Medicine SB RAS), [a-32P]GTP (1mCi/nmol), 4-(N-2-
-chloroethyl-N-methylamino)benzylamine (ClRCH2NH2)
and N-oxysuccinimide ester of 4-azidotetrafluorobenzoic
acid were synthesized in the Laboratory of Biotechnology
of this Institute.
Preparation of labeled HCV IRES RNA
The fragment corresponding to HCV RNA nucleotides
40–372 was obtained by in vitro transcription of plasmid
pXL40-372.NS (29) linearized by BamH1 (‘Fermentas’,
Lietuva) as described (17) using [a-32P]GTP. It was iso-
lated and examined as described (28). The specific radio-
activity of the RNA transcript was typically about 25 000
cpm/pmol.
Introduction of perfluorophenyl azide groups into the IRES
4-(N-2-chloroethyl-N-methylamino)benzyl-50-phosphor-
amides of oligodeoxyribonucleotides were synthesized and
purified as described (17). Site-specific modification of the
HCV IRES was carried out as described (28) starting
with 300 pmol of the RNA transcript. Isolation of the
RNA modified with deoxy-oligomers derivatives, determi-
nation of the modified RNA nucleotides, hydrolysis of
the phosphoramide bond in the deoxyribonucleotide deri-
vatives attached to the RNA, selective introduction of
perfluorophenyl azides at the aliphatic amine groups
liberated after hydrolysis and purification of the photoac-
tivatable derivatives of HCV IRES were carried out as
described (28).
Ribosomes, ribosomal complexes and cross-linking
procedures
40S ribosomal subunits with intact rRNA were isolated
from unfrozen human placenta as indicated (30). Prior
to use, the subunits were re-activated by incubation in
binding buffer A (20mM Tris–HCl, pH 7.5, 100mM
KCl, 2.5mM MgCl2 and 0.25mM spermidine) at 378C
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for 10min. Binary complexes of HCV IRES and 40S sub-
units were obtained by incubating the subunits
(2.0 106M if not specified otherwise) with IRES
(0.5 106M if not specified otherwise) in buffer A at
378C for 10min. The extent of binding of the 50-32P-
labeled RNAs to 40S subunits was examined by the nitro-
cellulose filtration assay using alkali pretreated filters as
described (31). In the experiments on the determination of
cross-linked ribosomal proteins, the binary complexes
were formed starting from 10–20 pmol of the derivatized
HCV IRES. UV-irradiation of the complexes was carried
out according to (25). The distribution of the cross-linked
labeled IRES between the rRNA and ribosomal proteins
was examined by centrifugation in a 5–20% sucrose den-
sity gradient in the presence of SDS and EDTA as
described (32).
Isolation and identification of ribosomal proteins cross-linked
to HCV IRES derivatives
To isolate ribosomal proteins, the irradiated complexes
were treated under conditions for dissociation of the sub-
units into the rRNA and proteins and exhaustively hydro-
lyzed with RNases A and T1 according to (28). The
proteins were separated from oligoribonucleotides by
gel-filtration and analyzed by 1D and 2D PAGE as
described (28). To analyze cross-linked proteins by immu-
noprecipitation, we used rabbit antibodies against pro-
teins S2 and S3, goat antibodies against proteins S3a
and S13/S16 and sheep antibodies against protein S14
obtained as described (33). These antibodies did not
cross-react with other 40S proteins. Irradiated binary
complexes of the 32P-labeled IRES derivatives and 40S
subunits were supplied with 2-mercaptoethanol, SDS
and EDTA to final concentrations of 0.2%, 0.1% and
10mM, respectively, together with 100 pmol of unlabeled
IRES. The mixture was incubated at 378C for 10min to
dissociate the subunits into rRNA and proteins and then
diluted with TBS (20mM Tris–HCl, pH 7.5, 150mM
NaCl and 0.4% Triton X-100). The antibodies were
immobilized on protein-G-Sepharose (Fluka) by stirring
20 ml of the sorbent suspension with 5–20 ml of a solution
containing 50mM Tris–HCl, pH 9.0, 4M urea and 0.3mg
antibodies for 2 h at 08C. The supernatant was discarded
and the sorbent was washed three times with 100ml TBS.
To prevent unspecific binding of RNAs and cross-linked
proteins to protein-G-Sepharose, the washed sorbent with
immobilized antibodies was supplied with 20 ml of a solu-
tion containing 1 A260 unit of total Escherichia coli tRNA
and bovine serum albumin (final concentration of 0.5mg/
ml); the mixture was incubated 1 h at 08C with stirring.
The supernatant was discarded and the sorbent was mixed
with a solution containing cross-linked proteins and incu-
bated for 3 h at 08C. The sorbent with bound cross-linked
proteins was pelleted by low-speed centrifugation, washed
five times with TBS buffer (100ml each time) and their
radioactivity was measured by Cherenkoff counting. The
values obtained with antibodies in a control experiment
with unmodified IRES were subtracted from the values
obtained with IRES derivatives.
RESULTS
HCV IRES derivatives
To introduce photoactivatable perfluorophenyl azide
groups into hairpin IIId or the apex of domain II of the
IRES (Figure 1), an approach based on the site-specific
alkylation of RNA with phosphoramide derivatives of
deoxyribonucleotides described previously (28) and sche-
matically shown in Figure 2a was applied. To increase the
yield of IRES alkylation with the derivatives of deoxy-
oligomers complementary to sequences 259–276 and
62–81, helper oligomers were used that facilitate binding
of oligomers bearing the alkylating group to the struc-
tured RNA [see (34) and Refs. therein] (Figures 1
and 2b). Helpers were not used in the experiments with
the derivative of oligomer complementary to sequence
248–267 since the yield of HCV IRES alkylation was suf-
ficiently high. The covalent adducts resulting from IRES
alkylation with the oligonucleotide derivatives were sepa-
rated from unmodified RNA by denaturing PAGE on an
8% gel (the respective electrophoregrams are not shown).
Generally, about 50% of the RNA was converted into the
covalent adduct in the course of alkylation.
To identify modified IRES nucleotides, reverse tran-
scription was used that makes it possible to detect mod-
ified nucleotides by stop or pause of primer extension. The
modification site is generally assumed to be the nucleotide
50 of the primer extension stop site. Therefore, stops at
A276 (Figure 3a, left panel, lane 1), U264 (left panel,
lane 2) and C84 (right panel, lane 3) correspond to mod-
ified A275, G263 and C83, respectively (Figures 1 and 2b).
With HCV IRES alkylated with the derivative of oligomer
complementary to sequence 248–267, a weaker stop at
G263 was also observed (Figure 3a, left panel, lane 2).
This signal could not be assigned to the primer extension
stop caused by the modification of U262 since uridine is
unable to react with aromatic 2-chloroethyl amines at
nearly neutral pH (35). Thus, the signal at nucleotide in
position 263 was assigned to a pause of reverse transcrip-
tion that could occur at guanine alkylated on the N7
atom, which is not involved in Watson–Crick base pairing.
One could expect that in the heteroduplex of the HCV
IRES with the derivative of oligomer complementary to
sequence 248–267 the alkylating group is located closer to
nucleotides G265–267 rather than to G263 (Figure 1). The
unusual target of alkylation in this case might be due to
peculiarities of the spatial structure of the IRES and also
to the low reactivity of guanines in oligoG fragments
towards alkylation with aromatic 2-chloroethyl amines
(36). Weaker stops with the derivative of oligomer com-
plementary to sequence 62–81 probably correspond to
minor alkylation sites adjacent to C83 (taking into
account the discussion above, these are G82 and A81).
To introduce a photoactivatable moiety on modified
RNA nucleotides, the phosphoramide bond in the cova-
lent adducts obtained from 32P-labeled IRES was hydro-
lyzed under mild acidic conditions (pH 4.1) that resulted
in the release of the aliphatic amino group RCH2NH2
linked to the RNA. The modified IRES RNAs were pur-
ified by denaturing 8% PAGE and the RCH2NH2 moi-
eties were selectively derivatized by treatment with the
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N-oxysuccinimide ester of 4-azidotetrafluorobenzoic acid.
HCV IRES derivatives bearing photoactivatable groups at
nucleotides A275, G263 or C83 were thus obtained
(Figures 1 and 2b). These derivatives were used in the
cross-linking experiments with human 40S ribosomal sub-
units in parallel with control HCV IRES (K) treated under
identical conditions but without addition of alkylating
derivatives of oligodeoxyribonucleotides.
Figure 2. Scheme of site-specific introduction of a photoactivatable group into specific RNA sites based on the site-specific alkylation of the RNA
with [4-(N-2-chloroethyl-N-methylamino)benzyl]-phosphoramides of oligodeoxyribonucleotides. (a) Order of chemical reactions. (b) Nucleotide
sequence of HCV IRES. Target sequences for the deoxy-oligomer derivatives are given in bold, the respective complementary oligodeoxyribonucleo-
tides are shown with either gray or black lines under the sequence, and the letters ‘p’ indicate the terminal 50-phosphates derivatized with alkylating
groups. Helper oligomers are shown by dotted lines. Lines with arrows above the sequence indicate primers used for reverse transcription (arrows
show the direction of primer extension). RNA sequences complementary to the primers are given in italics. Either gray or black vertical arrows show
cross-linked nucleotides.
Figure 3. Identification of sites of cross-linking of oligonucleotide derivatives to the HCV IRES by reverse transcription and binding properties of the
HCV IRES derivatives. (a) Extension of [50-32P]-labeled primers complementary to the HCV IRES sequences 331–350 (left panel) and 103–120 (right
panel). Lanes 1, 2 and 3, primer extension on HCV IRES alkylated with derivatives of deoxy-oligomers complementary to the sequences 259–276, 248–267
and 62–81, respectively. Lanes K, primer extension with control HCV IRES incubated under conditions of alkylation but without oligomer derivatives.
Lanes U, G, C, A, sequencing of HCV IRES. Arrows indicate positions of the reverse transcription stops caused by the cross-links. (b) Isotherms
of binding of control unmodified HCV IRES (K) and its derivatives containing a perfluorophenyl azide group at A275, G263 or C83 to 40S subunits
(1, 2 and 3, respectively). The initial concentration of the HCV IRES or its derivatives was 1.0 107M. Relative error was about 10%.
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Binding and cross-linking of photoactivatable HCV IRES
derivatives to 40S subunits
Filter retention assays revealed that the affinities of HCV
IRES derivatives bearing the cross-linker at A275, G263
or C83 to 40S subunits were similar to each other and did
not significantly differ from that of unmodified IRES
(Figure 3b) as was shown previously with HCV IRES sim-
ilarly derivatized at the nucleotides A296 and G87 (28).
For the cross-linking experiments, saturating concentra-
tions of 40S subunits were used. To obtain the cross-
links, the binary complexes of the IRES derivatives and
the 40S subunits were irradiated with mild UV light
(>280 nm). Subsequent analyses of the distribution of
the radioactive label between the rRNA and the ribosomal
proteins after centrifugation in sucrose density gradients
containing SDS and EDTA did not reveal radioactivity in
the fractions containing 18S rRNA (the respective sedi-
mentation profiles are not presented). Radioactivity was
found only in the top fractions containing proteins and
IRES not cross-linked to ribosomal components.
Therefore, none of the HCV IRES derivatives cross-
linked to the rRNA.
Identification of ribosomal proteins cross-linked to the
photoactivatable HCV IRES derivatives
Ribosomal proteins cross-linked to derivatives of the
IRES were first resolved by 1D SDS–PAGE. Prior to
analysis, the RNA cross-linked to proteins was exhaus-
tively hydrolyzed with RNases A and T1; ribosomal pro-
teins were separated from labeled oligoribonucleotides
resulting from hydrolysis by gel-filtration under strongly
denaturing conditions (6M guanidine chloride) to
decrease possible effects related to unspecific binding of
oligoribonucleotides to the proteins. The results presented
in Figure 4 show that all IRES derivatives cross-linked
mainly to two protein groups corresponding to the
bands ‘x’ in the upper and ‘y’ in the lower parts of the
gel, the intensities of the bands depending on the location
of the cross-linker in the IRES. With the IRES derivatized
at C83, the yield of cross-linking was significantly lower
than with the two other derivatives (Figure 4). It should be
also noted that in the lane corresponding to the control
RNA (lane K), weak diffuse bands appeared at positions
similar to those of ‘x’ and ‘y’. These bands clearly origi-
nated from a small portion of unspecific complexes of
ribosomal proteins with labeled oligoribonucleotides
resulting from hydrolysis of the IRES and remaining in
the protein fraction after gel-filtration (see above), and not
separated from the proteins even under conditions of
SDS–PAGE.
To identify candidate cross-linked proteins, we took
into account our previous data (25,26) allowing evaluation
of the effect of oligoribonucleotides cross-linked to
ribosomal proteins based on their electrophoretic mobili-
ties. Moreover, exhaustive hydrolysis of HCV IRES
with RNases A and T1 should produce fragments
ApApApGp, GpUp and CpCp/Cp (asterisks indicate
modified nucleotides) cross-linked to proteins in the case
of the HCV IRES derivatized at the A275, G263 and
C83, respectively (Figures 1 and 2b). These fragments
somewhat decrease the electrophoretic mobility of the
cross-linked proteins (the greater the molecular mass of
the protein, the lower the effect of the cross-linked oligo-
mer). Considering all these factors, one could suggest that
bands ‘x’ might correspond to cross-linked proteins S2/
S3a and less probably to protein S6, and bands ‘y’ to
cross-linked proteins S14/S16/S19/S23/S26. With the
IRES derivatized at A275 and at G263, a minor band in
the middle of the electrophoregram was also detected; its
position with respect to proteins S9, S7 and S5 was very
similar to that of cross-linked S5 in the experiments with
the IRES derivatized at A296 (28). With IRES modified at
A275 an additional weak band could be seen at position
corresponding to a single protein p40, which was shown
earlier to cross-link to A296 in subdomain IIIe (28).
Cross-linked protein(s) were more precisely identified
resolving them after exhaustive hydrolysis of HCV IRES
with RNAses A and T1 by ‘basic-SDS’ 2D PAGE (separa-
tion in the first dimension was at pH 8.3, and in the second
dimension at pH 6.75 in the presence of SDS), the results
are presented in Figure 5. Cross-linked proteins were iden-
tified considering that in the electrophoretic system used,
oligoribonucleotide fragments cross-linked to proteins
decrease their mobilities in the first dimension but
barely affect their migration in the second dimension.
Consequently, the radioactive spot of the cross-linked pro-
tein should be somewhat shifted to the left of the corre-
sponding stained spot of the unmodified protein. The
extents of the shifts were evaluated based on data of our
previous studies on cross-linking of short mRNA analo-
gues to ribosomes (25,26). The results showed that HCV
IRES derivatized at the A275 and the G263 cross-linked to
the same three groups of proteins, namely, to S3/S3a (less
probably, S2), S10/S15/S14 and S13/S16 (much less
Figure 4. Autoradiogram of the 40S ribosomal proteins cross-linked to
the 32P-labeled derivatives of HCV IRES by 1D PAGE in the presence
of SDS. Nucleotides bearing the cross-linker are indicated. Lane K,
proteins isolated from an irradiated control complex of unmodified
HCV IRES with 40S subunits. Lane TP40, silver stained gel; positions
of the 40S ribosomal proteins are indicated (43,44).
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probably, S25), the distribution of cross-links between
these groups depended on the location of the cross-linker
in the HCV IRES (Figure 5a and b). With C83-modified
IRES, only two spots corresponding to cross-linked pro-
teins S10/S15/S14 and S13/S16 were detected (Figure 5c).
Given the results of the 1D gels (Figure 4), more exact
identification of the cross-linked proteins could be per-
formed. In the group S13/S16/S25, only protein S16 was
actually cross-linked since S13 and S25 were not among the
candidate cross-linked proteins (see above). For the same
reason, proteins S10 and S15 could be excluded from
the group S10/S15/S14 and the only cross-linked protein
was S14. Similarly, protein S3a could be identified as the
only cross-linked protein in the group S3/S3a. Thus, com-
bining the data of 1D and 2D PAGE made it possible to
conclude that all HCV IRES derivatives used here cross-
linked mainly to proteins S14 and S16, and the derivatives
bearing the modifying group at A275 or G263 also cross-
linked to protein S3a (Figure 5d).
The identity of the cross-linked proteins S3a, S14 and
S16 was confirmed by immunoprecipitation using specific
antibodies. In parallel, immunoprecipitation with anti-
bodies against proteins S2 and S3 whose modification
was practically excluded on the basis of the comparison
of the results of 1D and 2D PAGE analysis was carried
out as control. The results shown in Figure 6 are in a good
accordance with the data of 1D and 2D PAGE separa-
tions discussed above (Figure 5) and confirm cross-linking
of the HCV IRES derivatives to ribosomal proteins S3a,
S14 and S16.
DISCUSSION
Choice of sequenceswithin theHCVIRES for the site-specific
introduction of cross-linker and binding properties of the
derivatized IRES
The criteria for the choice of derivatives of oligonucleo-
tides for introduction of cross-linker into the HCV IRES
were based on our earlier data on alkylation of the IRES
with the derivatives of oligodeoxyribonucleotides comple-
mentary to its specific sequences and testing abilities of the
resulting covalent adducts to bind to the 40S subunits (17).
The oligos were 20-mers that was enough to enable them
to form relatively stable heteroduplexes specifically with
the target sequences, and contained an alkylating group at
the 50-termini. This group generally modifies RNA nucleo-
tides near the 50-end of the oligomer bound to the RNA,
the more accessible is target RNA sequence, the higher
is yield of the covalent adduct (34). To increase the
Figure 6. Analysis of 40S proteins cross-linked to 32P-labeled HCV IRES derivatives (nucleotides bearing the cross-linker are indicated at the top) by
immunoprecipitation using antibodies against mammalian 40S ribosomal proteins (indicated at the bottom).
Figure 5. Analysis by 2D PAGE of proteins cross-linked to 32P-labeled
HCV IRES derivatives in the binary complexes with the 40S subunits.
(a–c), The autoradiograms correspond to the experiments with HCV
IRES derivatives containing the cross-linker at nucleotide A275, G263
or C83 (marked in the respective panels). (d), Coomassie stained gel
corresponding to (b) (as example); the positions of the proteins are
indicated (44, 45). The locations of the radioactive spots corresponding
to the cross-linked proteins are indicated on the stained gel by dotted
lines. The cross-linked proteins are highlighted by an asterisk (), and
are also in bold in (d).
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yields of the covalent adducts, we used helper oligomers to
disrupt the IRES secondary structure in the target region
and thus to facilitate formation of the heteroduplexes with
alkylating derivatives. We found that affinity of 40S sub-
units for the HCV IRES covalent adducts bearing deoxy
oligomers complementary to sequences in hairpin IIId and
IIIe was drastically lower than that for the unmodified
IRES (17). In contrast, attachment of a deoxy oligomer
complementary to the apical loop of domain II barely
affected the affinity of the IRES for the 40S subunits
(17). These results confirmed earlier data (12–16,18) that
HCV IRES subdomains IIId and IIIe are the main deter-
minants for binding to 40S subunits and that domain II
does not contribute to the binding. Based on all these, we
chose target RNA sequences for site-specific introduction
of the cross-linker (Figure 1). Two of them were in hairpin
IIId [hairpin IIIe has been studied in our previous report
(28)] and third one was mainly in the stem of domain II to
introduce cross-linker to the middle of the apical loop
[since IRES derivative with a photoactivatable group on
the G87 used in our previous study (28) did not cross-
linked to the 40S subunit].
Binding experiments showed that introduction of an
aryl azide cross-linker at nucleotides C83, G263 and
A275 almost did not affect affinity of the HCV IRES to
the 40S subunits (Figure 3b). This implies that HCV IRES
modified at these nucleotides retained its functional activ-
ity in the binding to the 40S subunit. This conclusion
could be done on the IRES modified at nucleotides
G263 or A275 in subdomain IIId critical for the binding
to the 40S subunit as well as on the IRES modified at the
C83 in domain II, which is not essential for the binding
since apical hairpins of domain II and subdomain IIId
adopt similar folds (37). Besides, apical hairpin of
domain II does not interact with other subdomains of
the IRES (37) so modification in the loop should not
affect the IRES spatial structure.
Ribosomal components neighboring the HCV IRES on
the 40S subunit
Two proteins cross-linked to HCV IRES derivatives, S3a
and S16, were found previously to also cross-link using the
derivative bearing perfluorophenyl azide at A296 in sub-
domain IIIe (28). Besides, this latter derivative as men-
tioned above, cross-linked to proteins S5 and p40 but
much more strongly than the HCV IRES derivatives
used here that bore the modifying group in subdomain
IIId suggesting that these proteins are closer to hairpin
IIIe than to IIId. On the other hand, cross-linking to pro-
tein S14 was not found with HCV IRES bearing the mod-
ifying group in hairpin IIIe (28), which implies that this
protein likely neighbors subdomain IIId and the apical
loop of domain II but not subdomain IIIe. We failed to
find any cross-links of HCV IRES derivatized at the G87
(in the upper part of the stem of domain II) with the 40S
subunit in the binary complex (28), in contrast to the
derivative bearing the same cross-linker at C83 (in the
apical loop of domain II) used here (Figure 1). This is a
notable result since a distance between the C83 and the
G87 is within the length of the cross-linker (14 A˚) used in
this study (28). Therefore, we have a basis to suggest that a
distance between the C83 and the 40S subunit does fall
within the range of cross-linker action while the distance
from the G87 to the subunit does not. This means that the
apical loop of domain II in the binary complex is located
closer to the 40S subunit than the stem of this domain.
The results obtained in the present study and in our
previous report (28) significantly differ from data of two
earlier reports on the determination of the 40S subunit
components neighboring the IRES as a whole during ini-
tiation of the viral RNA translation discussed in the
Introduction (19,20). In the article by Otto et al. (20),
proteins S2, S3, S10, S15, S16/S18 and S27 were reported
to be cross-linked, of which S3, S2 and S27 were the major
targets. It is now clear that a significant part of this set of
proteins, namely, proteins S2, S3 and S15, belongs to the
environment of the mRNA at the decoding site and down-
stream of it. This is based on data on cross-linking of these
proteins in 80S ribosomal complexes to unstructured
mRNA analogues with perfluorophenyl azide-modified
nucleotides in positions +4 to +12 (25,26) or with
4-thiouridines in positions +4 to +7 (38) with respect
to the first nucleotide of the P site codon. Recently these
results were confirmed with 4-thiouridine-containing
mRNAs in the 48S/80S initiation complexes, in which
the modified nucleotide in position +11 cross-linked to
proteins S3 and S2, and in positions +4/+5 cross-
linked to protein S15 (27). On the cryo-EM images of
the 40S subunit (39), locations of proteins S2 and S3 are
similar to those of their prokaryotic counterparts S5p and
S3p in the 30S subunit that form the mRNA entry site,
and S15 lies on the intersubunit side of the small subunit.
All these point to unlikely neighborhood of the mentioned
proteins and the 50-untranslated part of HCV IRES.
Thus, we have all reasons to suggest that proteins S2, S3
and S15 found in the report (20) cross-linked not to the
50-untranslated region of the HCV IRES but to the part of
the coding sequence domain IV according to the structure
presented in (8) that could contain 4-thiouridines in posi-
tions +2, +10 and +13. Consequently, only proteins
S10, S16/S18 and S27 can be considered as cross-linked
to the 50-untranslated region of the HCV RNA in the
binary complex. This set overlaps the set found here
only by protein S16. One possible explanation for this
discrepancy is that proteins S10 and S27 could be cross-
linked to 4-thiouridines located in IRES positions far from
C83, G263, A275 or A296 that bore perfluorophenyl azide
cross-linkers. As for the data presented in (19), they
cannot be compared directly with our results because in
the former experiments, mixtures of HCV IRES and HeLa
cytoplasmic extracts but not the purified binary complexes
were used for irradiation. This did not make it possible to
specify which steps of HCV RNA translation were
monitored.
Our results reported here and previously (28) provide a
view of the molecular environment of subdomains IIId/e,
the main determinants for HCV IRES binding to the 40S
subunit, and of the apical loop of domain II, which was
suggested to locate close to the head of the subunit near
protein S5 and the mRNA exit site on the basis of cryo-
EM data (22). According to our results, protein S14
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neighbors both sides of the stem of subdomain IIId and
the apical loop of domain II, protein S16 is located close
to both hairpins IIId/e and to the apical loop of domain
II, protein S3a neighbors hairpins IIId/e, and proteins S5
and p40 are mainly close to subdomain IIIe. Remarkably,
no cross-links to the 18S rRNA were detected confirming
the earlier suggestion that ribosomal proteins but not the
18S rRNA play the main role in binding of the HCV IRES
to the 40S subunit (20).
The sets of ribosomal proteins cross-linked to perfluor-
ophenyl azide-derivatized HCV IRES partially overlapped
the sets of proteins cross-linked in the 80S ribosomal com-
plexes to mRNA analogues that bore similar cross-linkers
at nucleotides in positions 9 to +12 (25,26). Only pro-
tein S14 cross-linked both to HCV IRES derivatives and
to mRNA analogues bearing cross-linkers in positions 6
to 9 (25). Protein S14 was also cross-linked to mRNAs
bearing 4-thiouridine in the mentioned positions; besides,
protein S5 was cross-linked to 4-thiouridines in positions
3/4 (27). Proteins S5 and S14 are homologous to pro-
karyotic S7p and S11p, respectively that are known as
constituents of the 30S ribosomal exit site of the mRNA
(40). Thus, the HCV IRES site has minor overlap with the
mRNA-binding channel and is located near the mRNA
exit site.
Location of HCV IRES on the 40S subunit
We applied our cross-linking results to the cryo-EM
model of the mammalian 40S ribosomal subunit (39)
(Figure 7a) and compared the location of the IRES
cross-linked to the proteins with its position on the 40S
subunit in the binary complex deduced from cryo-EM
data (21) (Figure 7b). Cryo-EM data on the 80S ribosomal
complex with HCV IRES (22) were not considered since
this complex reflects other steps of initiation of viral RNA
translation. It should be noted that comparison of our
results with cryo-EM-derived data has its limitations
since only positions of the conserved parts of ribosomal
proteins could be mapped on the models derived from
cryo-EM data, while the IRES likely interacts with
higher eukaryote-specific sequences of the proteins (20)
(mentioned in the Introduction section). Nevertheless,
the cross-linking results as a whole are in good agreement
with the data obtained by cryo-EM reconstitution of the
binary complex of HCV IRES with the 40S subunit (com-
pare Figure 7a and b). Clearly, all the cross-linked pro-
teins are located mainly on the solvent side of the 40S
subunit opposite the beak around the cleft between
the head and the body, near a site homologous to the
mRNA exit site in the 30S subunit and overlapping the
E site. The only pronounced dissimilarity between our
cross-linking results and the cryo-EM data is that protein
S5 appears to neighbor subdomain IIIe (28) rather than
domain II (21). This in fact is not a real discrepancy
because the absence of cross-link cannot indicate lack of
interaction [for a detailed discussion, see (28)], and our
results do not exclude possible interaction of protein S5
with domain II of HCV IRES.
Protein S3a neighboring the HCV IRES according to
our data has no prokaryotic counterparts, and therefore
its position on the eukaryotic 40S subunit remains
unknown. It is conceivable that this protein is located in
the same region of the subunit as p40, S5, S14 and S16,
namely on the solvent side of the head far from the beak.
On the cryo-EM map of the mammalian 40S ribosomal
subunit, density corresponding to eukaryote-specific pro-
teins appears close to proteins S14, S5 and p40 (39). A
protein density located at the platform near proteins S14
and p40 most likely conforms position of S3a since earlier
immunoelectron microscopy studies showed that antibo-
dies against S3a bound at the mentioned region (41).
Thus, our cross-linking results provide significant novel
information on the organization of the HCV IRES-bind-
ing site on the 40S ribosomal subunit in the binary com-
plex, which forms during the first step of translation
initiation of the viral RNA, highlighting the key role
played by the ribosomal proteins p40, S3a, S5, S14 and
S16 in the organization of this site. The binding sites of
various IRESes on the 40S subunit could be significantly
different. For instance, in contrast to the HCV IRES,
Cricket paralysis virus (CrPV) IRES is located entirely
in the mRNA-binding cleft, reaching into the P and A
sites (42). Nevertheless, both IRES-binding sites share
some extent of similarity: both CrPV IRES and HCV
IRES neighbor protein S5 and moreover, the CrPV
IRES is located close to S16 as seen upon comparing the
models presented in (21,39,42). It is reasonable to suggest
also that proteins play a key role in the formation of the
40S ribosomal-binding site not only for HCV IRES but
Figure 7. Structural model of the mammalian 40S ribosomal subunit
(a) and of the complex of the 40S subunit with HCV IRES (b) obtained
from cryo-EM data. View from the solvent side. (a) Model of the 40S
subunit of the elongating ribosome [adapted from (39), PDB accession
number 2ZKQ]. Locations of ribosomal proteins cross-linked to HCV
IRES nucleotides belonging to domain II and subdomains IIId (this
study) and IIIe (17) are shown (p40 in orange, S5 in purple, S14 in dark
blue and S16 in red), prokaryotic homologues of these proteins are
indicated in brackets. All other proteins that have prokaryotic counter-
parts are shown in green and proteins specific for eukaryotes are not
shown; gray balls represent the 18S rRNA. (b) Surface representation
of the 40S ribosomal subunit in complex with the HCV IRES [adapted
from (21)]. The cryo-EM map is in yellow. The difference map corre-
sponding to the HCV IRES is superimposed and presented in purple.
The suggested location of hairpins IIId/e is boxed. Asterics show sites
of conformational changes in the 40S subunit caused by HCV IRES
binding.
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also for other IRESes. However, we cannot extend this
suggestion to the later steps of initiation of translation
of viral RNAs since in the 80S ribosomal complex with
HCV IRES, close proximity of the IRES with 18S rRNA
helices was detected (22).
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